NCT00050921 - Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2005

Conditions

HIV Infections

Interventions

DRUG

somatropin

BIOLOGICAL

Hepatitis A virus, inactivated

DRUG

Keyhole-Limpet Hemocyanin

Trial Locations (13)

Beth Israel Med. Ctr., ACTU, New York

Alabama Therapeutics CRS, Birmingham

Case CRS, Cleveland

MetroHealth CRS, Cleveland

Univ. of Iowa Healthcare, Div. of Infectious Diseases, Iowa City

Northwestern University CRS, Chicago

Rush Univ. Med. Ctr. ACTG CRS, Chicago

Univ. of Texas Southwestern Med. Ctr., Amelia Court Continuity Clinic, Dallas

University of Colorado Hospital CRS, Aurora

UCLA CARE Center CRS, Los Angeles

Ucsf Aids Crs, San Francisco

UC Davis Medical Center, Sacramento

Univ. of California Davis Med. Ctr., ACTU, Sacramento

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH